Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions

Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions

US Patent 12163150 · Granted Dec 10, 2024

Estimated economic value: $399,846,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lassa vaccine2024
Hepatitis B immunization regimen and compositions2024
Recombinant measles virus expressing zika virus prM and E proteins2024
Recombinant measles vaccine expressing hTERT2022
Live recombinant measles-M2 virus—its use in eliciting immunity against influenz2021
Dengue virus chimeric polyepitope composed of fragments of non-structural protei2021
Compositions and methods comprising measles virus defective interfering particle2021
Use of a genetically modified infectious measles virus with enhanced pro-apoptot2021
Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use f2020
Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use f2020
Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use f2020
Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use f2020